Breaking News Instant updates and real-time market news.

TRX

Tanzanian Gold

$0.78

-0.047 (-5.68%)

16:20
11/04/19
11/04
16:20
11/04/19
16:20

Tanzanian Gold provides update on Buckreef Project

Tanzanian Gold's board provide shareholders with a guide to the progress that the Buckreef Project has made since the company acquired it. This guide is based on the 43-101 Standard of Reporting. Regulators in Canada require that on any significant matter related to mining, listed companies must follow National Instrument 43-101. Disclosures covered by NI 43-101 include news releases of mineral exploration results, reporting of resources and reserves, technical studies, various levels of feasibility studies, presentations, oral comments, and websites. The company said, "Various authorities have stated that it takes at least 10 years for a mining project to move from exploration to completion of a Final Feasibility Study and Environmental Impact Study, both of which are generally required for government permits, financing and developing comprehensive construction plans. The Company firmly believes that, as illustrated by this guide to NI 43-101, the Buckreef Project has made significant advances. In June 2018, the Company published a comprehensive Pre-Feasibility Study. The authors of this study concluded that the Buckreef Project "is likely to be technically and economically feasible". Highlights of that study, which was done at a gold price of $1,300 per oz are: an after-tax US$ NPV discounted at 5% of $131 million; an IRR of 74%; a capital payback period of 4 years; and an average LOM cash cost of US$ 735 per oz. The Buckreef Project is now one step away from a Final Feasibility Study. Despite the attractive metrics arising from the Pre-Feasibility Study, the Company decided to see if the Buckreef Project can be made bigger and better; and to start to collect the technical data to move the project to the Final Feasibility Stage. To date, the Buckreef Project has; Drilled over 10,000m using at times three drill machines operating 24 hours per day, Developed a geology-resource model of the entire Buckreef Mineralized Zone using technologically advanced data-mine software that will be used for future resource and reserve estimates,Initiated a comprehensive metallurgical review and test data based on a plant that is two times larger than the plant in the Pre-Feasibility Study, and Initiated a rock stress test program to determine the possibility of mining underground below the pit bottom. It is the Company's intention to make a Conceptual Study that incorporates all the new drilling results from the 2019 drill program as well as the data arising from the metallurgical and rock stress tests. This Conceptual Study will most likely be based on a larger open pit than that in the Pre-Feasibility Study and an underground mine that can access resources below the pit bottom. This Study will assist the Company to determine the key parameters of a Final Feasibility Study of the Buckreef Project..."

TODAY'S FREE FLY STORIES

ATDRY

Auto Trader Group

$0.00

(0.00%)

05:53
12/13/19
12/13
05:53
12/13/19
05:53
Upgrade
Auto Trader Group rating change  »

Auto Trader Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDNNY

Boliden

$0.00

(0.00%)

05:51
12/13/19
12/13
05:51
12/13/19
05:51
Downgrade
Boliden rating change  »

Boliden downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$220.43

0.37 (0.17%)

, REGN

Regeneron

$372.10

-1.41 (-0.38%)

05:39
12/13/19
12/13
05:39
12/13/19
05:39
Recommendations
Vertex, Regeneron analyst commentary  »

Credit Suisse replaces…

VRTX

Vertex

$220.43

0.37 (0.17%)

REGN

Regeneron

$372.10

-1.41 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

OPI

Office Properties

$32.93

-1.02 (-3.00%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Downgrade
Office Properties rating change  »

Office Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

$0.00

(0.00%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Hot Stocks
Volvo appoints Scott Rafkin as Chief Digital Officer »

Scott Rafkin, currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$236.18

2.22 (0.95%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Recommendations
Amgen analyst commentary  »

Amgen price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Upgrade
Nordson rating change  »

Nordson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$111.41

-1.85 (-1.63%)

05:35
12/13/19
12/13
05:35
12/13/19
05:35
Downgrade
Neurocrine rating change  »

Neurocrine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

05:35
12/13/19
12/13
05:35
12/13/19
05:35
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos

$214.12

-0.74 (-0.34%)

05:33
12/13/19
12/13
05:33
12/13/19
05:33
Downgrade
Galapagos rating change  »

Galapagos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GILD

Gilead

$67.64

0.5 (0.74%)

05:31
12/13/19
12/13
05:31
12/13/19
05:31
Downgrade
Gilead rating change  »

Gilead downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

05:29
12/13/19
12/13
05:29
12/13/19
05:29
Upgrade
Biogen rating change  »

Biogen upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$372.10

-1.41 (-0.38%)

05:26
12/13/19
12/13
05:26
12/13/19
05:26
Upgrade
Regeneron rating change  »

Regeneron upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, EXEL

Exelixis

$17.68

0.05 (0.28%)

05:25
12/13/19
12/13
05:25
12/13/19
05:25
Hot Stocks
Genentech says Phase III IMspire150 study met primary endpoint of PFS »

Genentech, a member of…

RHHBY

Roche

$0.00

(0.00%)

EXEL

Exelixis

$17.68

0.05 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

HTHT

Huazhu Group

$34.86

0.92 (2.71%)

05:23
12/13/19
12/13
05:23
12/13/19
05:23
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:22
12/13/19
12/13
05:22
12/13/19
05:22
Hot Stocks
Genentech says Phase III IMspire150 study met primary endpoint of PFS »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

SNAP

Snap

$14.45

0.22 (1.55%)

05:19
12/13/19
12/13
05:19
12/13/19
05:19
Upgrade
Snap upgraded to Outperform from Market Perform at JMP Securities »

JMP Securities analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$92.79

-2.2 (-2.32%)

05:16
12/13/19
12/13
05:16
12/13/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PCG

PG&E

$11.75

-0.38 (-3.13%)

05:14
12/13/19
12/13
05:14
12/13/19
05:14
Hot Stocks
PG&E files amended plan of reorganization »

PG&E Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

05:12
12/13/19
12/13
05:12
12/13/19
05:12
Recommendations
Sarepta price target raised to $210 from $185 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$11.81

-2.68 (-18.50%)

05:07
12/13/19
12/13
05:07
12/13/19
05:07
Downgrade
Lovesac rating change  »

Lovesac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

05:04
12/13/19
12/13
05:04
12/13/19
05:04
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTMI

TTM Technologies

$13.79

0.19 (1.40%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Upgrade
TTM Technologies rating change  »

TTM Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Downgrade
Federated Investors rating change  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
AssetMark Financial rating change  »

AssetMark Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.